Stay updated on Risankizumab in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Risankizumab in Atopic Dermatitis Clinical Trial page.

Latest updates to the Risankizumab in Atopic Dermatitis Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedRecruitment status updated to 'No longer looking for participants' and new help/navigation sections are added (How to Read a Study Record, Common Questions, How to Join a Study), with a formatting tweak to the Intervention/Treatment label and a revision tag updated to v3.6.0.SummaryDifference0.2%

- Check17 days agoChange DetectedThe page shows a new revision label (v3.5.5) replacing the previous v3.5.4. This indicates a minor update to the page without altering study content or data.SummaryDifference0.0%

- Check38 days agoChange DetectedRevision: v3.5.4 has been added, replacing the previous revision. This update appears to be a minor software/policy change that does not alter study details or user-facing information on the page.SummaryDifference0.0%

- Check59 days agoChange DetectedThe page’s footer “Revision” indicator has been updated from v3.5.2 to v3.5.3, reflecting a site version change without altering the study details presented.SummaryDifference0.0%

- Check66 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2; additions: v3.5.2, deletions: v3.5.0.SummaryDifference0.0%

- Check95 days agoChange DetectedRevision: v3.5.0 added and Revision: v3.4.3 removed. This appears to be a minor version-label update and does not modify study content or functionality.SummaryDifference0.0%

Stay in the know with updates to Risankizumab in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Risankizumab in Atopic Dermatitis Clinical Trial page.